慢性肾脏病患者在法国全科医疗中心的管理现状:数据库分析
该回顾性单中心研究分析了2012至2017年法国Maison de Neufchâtel全科医疗中心成人患者的电子病历,以两次间隔3个月以上eGFR<60 mL/min为纳入标准,共纳入291例(6.7%,95%CI 5.9–7.4)CKD患者。研究描述了其临床与生物学监测及处方治疗情况,发现CKD存在筛查不足和管理不足,且电子病历中CKD编码与更完善的生物学监测相关。
要点
- CKD患者中66.7%使用肾保护药物,33%未使用任何肾保护药物。
- 47%患者使用质子泵抑制剂(PPI),8%使用非甾体抗炎药(NSAIDs)等肾毒性药物。
- 电子病历中录入CKD编码者,其血钠、白蛋白尿、维生素D和磷的检测更充分。
核心结论
- 这项试点研究支持CKD在全科医疗中存在筛查不足和管理不足的假设。
- 应更系统地在电子病历中编码医疗信息,并进一步开展医疗中心数据库研究以改善全科实践。
研究设计与样本
- 回顾性单中心研究,分析法国Maison de Neufchâtel全科医疗中心2012至2017年每年至少就诊一次的成人患者电子病历。
- 纳入标准为两次间隔3个月以上的eGFR测量值<60 mL/min,并根据电子病历中是否编码CKD分为两个亚组。
主要发现
- 共纳入291例(6.7%,95%CI 5.9–7.4)CKD患者,平均eGFR为51.0 ± 16.4 mL/min。
- 高血压是最常报告的健康问题(n = 93,32%)。
- 肾保护药物处方于194例(66.7%)患者,NSAIDs处方于22例(8%)患者,PPIs处方于147例(47%)患者。
- 临床监测因编码质量差而无法分析。
关键数值与推荐
- 电子病历中CKD编码与血钠检测(n = 34,100%,P < 0.01)、白蛋白尿检测(n = 20,58%,P < 0.01)、维生素D检测(n = 14,41%,P < 0.001)和磷检测(n = 11,32%,P < 0.001)相关。
临床怎么用
- 全科医生应重视CKD的早期识别,对eGFR<60 mL/min者规范检测白蛋白尿并系统编码。
- 处方肾保护药物时应评估肾毒性药物(如PPIs、NSAIDs)的使用并加强生物学监测。
局限性
- 临床监测数据因电子病历编码质量差而无法分析。
- 为单中心回顾性试点研究,结论需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE(S): Chronic kidney disease (CKD) is an insidious disease that requires early nephroprotective measures to delay progression to end-stage kidney disease. The objective of this study was to describe the management of patients with CKD in primary care, including clinical and biological monitoring and prescribed treatments. A retrospective, single-centre study was conducted on adult patients who were treated in the Maison de Neufchâtel (France) between 2012 and 2017 at least once a year. The inclusion criteria were 2 estimated glomerular filtration rate (eGFR) measurements <60 mL/min more than 3 months apart. Two subgroups were constituted according to whether CKD was coded in the electronic medical records (EMRs). RESULTS: A total of 291 (6.7%, CI95% 5.9-7.4) patients with CKD were included. The mean eGFR was 51.0 ± 16.4 mL/min. Hypertension was the most frequent health problem reported (n = 93, 32%). Nephrotective agents were prescribed in 194 (66.7%) patients, non-steroidal anti-inflammatory drugs (NSAIDs) in 22 (8%) patients, and proton-pump inhibitors (PPIs) in 147 (47%) patients. CKD coding in EMRs was associated with dosage of natraemia (n = 34, 100%, P < 0.01), albuminuria (n = 20, 58%, P < 0.01), vitamin D (n = 14, 41%, P < 0.001), and phosphorus (n = 11, 32%, P < 0.001). Eighty-one patients (31.5%) with low eGFR without an entered code for CKD were prescribed an albuminuria dosage. Clinical monitoring could not be analysed due to poor coding. CONCLUSION: This pilot study reinforces the hypothesis that CKD is underscreened and undermanaged. More systematic coding of medical information in EMRs and further studies on medical centre databases should improve primary care practices. Chronic kidney disease (CKD) is an insidious disease that requires early protective measures to delay progression to end-stage kidney disease. The aim of this study was to describe the management of patients with CKD in primary care. A study was conducted in France by analysing the medical records of adult patients between 2012 and 2017. Of 4,370 patients, 291 (6.7%) had CKD. Hypertension was the main associated medical history (32%) and was also known to be one of the main risk factors for CKD. Ninety-seven patients (33%) did not receive any medication indicated to protect the kidneys. Kidney-toxic drugs were widely prescribed, including PPIs in 47% of patients and NSAIDs in 8% of patients. Patients with a CKD note in their medical record had closer biological monitoring. This pilot study reinforces the hypothesis that CKD is underscreened and undermanaged. The coding of information in primary care and further studies on these databases should improve the practice of general practice.
引用
- Ariza M, Martin S, Dusenne M, et al. Management of patients with chronic kidney disease: a French medical centre database analysis. Fam Pract. 2024. PMID: 36708191. doi:10.1093/fampra/cmad004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。